Liver functional reserve estimation: State of the art and relevance for local treatments: The Eastern perspective

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 4, 2010, Pages 380-384

  Fan, Sheung Tat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Indocyanine green clearance test; Liver function

Indexed keywords

INDOCYANINE GREEN; COLORING AGENT; DIAGNOSTIC AGENT;

CHILD PUGH CLASSIFICATION; DISEASE CLASSIFICATION; HUMAN; INDOCYANINE GREEN CLEARANCE TEST; INTERMETHOD COMPARISON; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER INJURY; LIVER RESECTION; MORTALITY; REFERENCE VALUE; REVIEW; RISK FACTOR; HOSPITALIZATION; LIVER TUMOR; METABOLISM; REPRODUCIBILITY;

CARCINOMA, HEPATOCELLULAR; COLORING AGENTS; HUMANS; INDOCYANINE GREEN; LIVER FUNCTION TESTS; LIVER NEOPLASMS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 79952113528     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0229-9     Document Type: Review

References (37)

1. Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg. 2003;7:325-30. (Pubitemid 36875770)
2. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ, Edinburgh Liver Surgery and Transplantation Experimental Research Group (eLISTER). The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut. 2005;54:289-96.
3. Fan ST. Hepatectomy for hepatocellular carcinoma: towards zero hospital deaths. Ann Surg. 1999;229:322-30.
4. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg. 1999;134:984-92. (Pubitemid 29428911)
5. Khan AZ, Morris-Stiff G, Makuuchi M. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg. 2009;16:137-44.
6. Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 2nd English ed. Tokyo: Kanehara; 2003. p. 13-14.
7. Ichikama T, Uenishi T, Takemura S, Oba K, Ogawa M, Kodai S, et al. A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2009;16:42-8.
8. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464-70. (Pubitemid 32119037)
9. Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, Ercolani G, et al. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables. Arch Surg. 2009;144:57-63.
10. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. Improving perioperative outcome expands the role of hepatectomy. Ann Surg. 2004;240:698-708.
11. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg. 1997;84:1255-9. (Pubitemid 27400276)
12. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci. 1961;21:43-57.
13. Morris-Stiff G, Gomez D, Prasad R. Quantitative assessment of hepatic function and its relevance to the liver surgeon. J Gastrointest Surg. 2009;13:374-85.
14. Fan ST, Lai EC, Lo CM, Ng IO, Wong J. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg. 1995;130:198-203.
15. Lam CM, Fan ST, Lo CM, Wong J. Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg. 1999;86:1012-7. (Pubitemid 29387065)
16. Makuuchi M, Hasegawa H, Yamazaki S. Indication for hepatectomy in patients with hepatocellular carcinoma and cirrhosis (in Japanese). Shindan Chiryo. 1986;74:1225-30.
17. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005;12:16-22. (Pubitemid 40378835)
18. Ohwada S, Kawate S, Hamada K, Yamada T, Sunose Y, Tsutsumi H, et al. Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma. Br J Surg. 2006;93:339-46.
19. Purcell R, Kruger P, Jones M. Indocyanine green elimination: a comparison of the LiMON and serial blood sampling methods. ANZ J Surg. 2006;76(1-2):75-7.
20. de Liguori Carino N, O'Reilly DA, Dajani K, Ghaneh P, Poston GJ, Wu AV. Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure. Eur J Surg Oncol. 2009;35(9):957-62.
21. Hsieh CB, Chen CJ, Chen TW, Yu JC, Shen KL, Chang TM, et al. Accuracy of indocyanine green pulse spectrophotometry clearance test for liver function prediction in transplanted patients. World J Gastroenterol. 2004;10:2394-6.
22. Oellerich M, Armstrong VW. The MEGX test: a tool for the realtime assessment of hepatic function. Ther Drug Monit. 2001;23:81-92. (Pubitemid 32240134)
23. Zoedler T, Ebener C, Becker H, Roeher HD. Evaluation of liver function tests to predict operative risk in liver surgery. HPB Surg. 1995;9:13-8. (Pubitemid 26021905)
24. Fan ST, Wang QS, Lo CM, Tam Yu KW, Lai EC, Wong J. Evaluation of indocyanine green retention and aminopyrine breath tests in patients with malignant biliary obstruction. Aust N Z J Surg. 1994;64:759-62. (Pubitemid 24338935)
25. Shirin H, Aeed H, Shalev T, Sorin V, Stavinski S, Shahmurov M, et al. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats. J Gastroenterol Hepatol. 2008;23:1762-8.
26. Kiuchi T, Ozawa K, Yamamoto Y, Takayasu T, Maki A, Shimahara Y, et al. Changes in arterial ketone body ratio in the phase immediately after hepatectomy. Prognostic implications. Arch Surg. 1990;125:655-9.
27. Hanazaki K, Wakabayashi M, Sodeyama H, Makiuchi A, Igarashi J, Yokoyama S, et al. Arterial ketone body ratio does not correlate with ischemic changes during major hepatectomy. Hepatogastroenterology. 1998;45:145-9. (Pubitemid 28067544)
28. Hwang EH, Taki J, Shuke N, Nakajima K, Kinuya S, Konishi S, et al. Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT. J Nucl Med. 1999;40:1644-51. (Pubitemid 29471154)
29. Kwon AH, Matsui Y, Kaibori M, Ha-Kawa SK. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. Surgery. 2006;140:379-86.
30. Cheung TT, Ng KK, Poon RT, Fan ST. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2009;16(5):655-60.
31. Chan SC, Liu CL, Lo CM, Lam BK, Lee EW, Wong Y, et al. Estimating liver weight of adults by body weight and gender. World J Gastroenterol. 2006;12:2217-22.
32. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176-81. (Pubitemid 27509300)
33. Shiha G, Sarin SK, Ibrahim AE, Omata M, Kumar A, Lesmana LA, et al. Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int. 2009;3:323-33.
34. Fan ST, Lo CM, Liu CL. Major hepatic resection for primary and metastatic tumors. In: Fischer JE, Bland KI, Callery MP, LoGerfo FW, Clagett GP, Seeger JM, et al., editors. Mastery of surgery. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 1076-91.
35. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824-8.
36. Stockmann M, Lock JF, Riecke B, Heyne K, Martus P, Fricke M, et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg. 2009;250:119-25.
37. Cucchetti A, Ercolani G, Cescon M, Ravaioli M, Zanello M, Del Gaudio M, et al. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg. 2006;203:670-6. (Pubitemid 44648768)